Waters Corporation Reports Strong Q3 2024 Results and Raises Guidance

Details

GAAP EPS was $2.71, and non-GAAP EPS was $2.93, both significantly exceeding guidance. The company raised its full-year 2024 sales and EPS guidance. For the fourth quarter, the company expects constant currency sales growth of 5% to 7% and non-GAAP EPS of $3.90 to $4.10.

Items reported

Exhibits (1)

About Waters Corporation

Waters Corporation is a leading entity in the field of analytical instruments and software. It primarily focuses on providing laboratory solutions for a variety of sectors, including pharmaceuticals, healthcare, food and beverage, and chemical analysis. The company's offerings include high-performance liquid chromatography, mass spectrometry systems, and various supporting technologies used for advanced research in life sciences. Waters Corporation is pivotal in enhancing laboratory productivity, offering cutting-edge research tools that assist in drug development, quality control, and environmental testing. Operating globally, it serves a wide array of clients, including academic institutions, government agencies, and private industry players. With its commitment to innovation and precision, Waters Corporation plays a crucial role in advancing scientific and technological progress in multiple critical industries worldwide.